TABLE OF CONTENTS
Volume 14, Issue 2 (February 2007)
Review
Gene therapy targeting to tumor endothelium
M Bazan-Peregrino, L W Seymour and A L Harris
Cancer Gene Ther 14: 117-127; advance online publication, November 10, 2006; doi:10.1038/sj.cgt.7701001
Meeting Report
International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China
B A Guinn, J S Norris, F Farzaneh and A B Deisseroth
Cancer Gene Ther 14: 128-138; advance online publication, October 13, 2006; doi:10.1038/sj.cgt.7700996
Original Articles
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
T Au, S Thorne, W M Korn, D Sze, D Kirn and T R Reid
Cancer Gene Ther 14: 139-150; advance online publication, December 1, 2006; doi:10.1038/sj.cgt.7700988
A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy
Y-F Xu, L-P Zhu, B Hu, G-F Fu, H-Y Zhang, J-J Wang and G-X Xu
Cancer Gene Ther 14: 151-157; advance online publication, October 27, 2006; doi:10.1038/sj.cgt.7701003
Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2
T Yi, Y-Q Wei, L Tian, X Zhao, J Li, H-X Deng, Y-J Wen, C-H Zou, G-H Tan, B Kan, J-M Su, Y Jiang, Y-Q Mao, P Chen and Y-S Wang
Cancer Gene Ther 14: 158-164; advance online publication, November 24, 2006; doi:10.1038/sj.cgt.7700994
Saporin as a novel suicide gene in anticancer gene therapy
N Zarovni, R Vago, T Soldà, L Monaco and M S Fabbrini
Cancer Gene Ther 14: 165-173; advance online publication, September 29, 2006; doi:10.1038/sj.cgt.7700998
Protection of normal human reconstructed epidermis from UV by catalase overexpression
H R Rezvani, M Cario-André, C Pain, C Ged, H deVerneuil and A Taïeb
Cancer Gene Ther 14: 174-186; advance online publication, October 20, 2006; doi:10.1038/sj.cgt.7701000
Membrane-localized activation of glucuronide prodrugs by 
-glucuronidase enzymes
K-C Chen, T-L Cheng, Y-L Leu, Z M Prijovich, C-H Chuang, B-M Chen and S R Roffler
Cancer Gene Ther 14: 187-200; advance online publication, September 15, 2006; doi:10.1038/sj.cgt.7700999
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge
L Elia, L Aurisicchio, A Facciabene, P Giannetti, G Ciliberto, N La Monica and F Palombo
Cancer Gene Ther 14: 201-210; advance online publication, October 20, 2006; doi:10.1038/sj.cgt.7701004
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients
E Brouwer, M J Havenga, O Ophorst, B de Leeuw, L Gijsbers, G Gillissen, R C Hoeben, M ter Horst, D Nanda, C Dirven, C J Avezaat, J Goudsmit and P Sillevis Smitt
Cancer Gene Ther 14: 211-219; advance online publication, November 3, 2006; doi:10.1038/sj.cgt.7701010
Short Communication
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc
L C Boffa, G Cutrona, M Cilli, S Matis, G Damonte, M R Mariani, E Millo, M Moroni, S Roncella, F Fedeli and M Ferrarini
Cancer Gene Ther 14: 220-226; advance online publication, October 20, 2006; doi:10.1038/sj.cgt.7701002
